Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03711799 · ClinicalTrials.gov registry record · NA
Mind the Gap (AIR-B3)
A NA study of Autism Spectrum Disorder, sponsored by Health Resources and Services Administration (HRSA).
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
- 3
- Study locations
NCT03711799: Completed NA study of Autism Spectrum Disorder, sponsored by Health Resources and Services Administration (HRSA).
NCT03711799 is a NA study of Autism Spectrum Disorder that has completed, run by Health Resources and Services Administration (HRSA). The registered enrollment target is 156 participants, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (16% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03711799, a NA study of Autism Spectrum Disorder, has completed, sponsored by Health Resources and Services Administration (HRSA).
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
- 3
- Study locations
Study Summary
There has been a lack of research on the unique needs of families with autism in the African-American and Latino communities. The process of screening, evaluation and treatment for children with autism can be long and arduous, especially in these communities. This often means that the best interventions for children with autism are not reaching minority communities. For many families, the complexity of the services system leads to a long wait after the initial diagnosis before accessing intervention. This means that the children have delayed access to treatment. Mind the Gap is a study that seeks to provide immediate and culturally appropriate support for families who have just received diagnosis but have yet to receive treatment. This support will be provided in families' native languages and, through the use of phone and video sessions, can accommodate busy schedules. Mind the Gap participants will be randomized to receive one of two conditions, which are 1.Resources only (online training modules and paper or on line resource lists, but no peer coaching) 2. Peer coaching (will receive all online training access). The peer coaches will be recruited from local parent support agencies. They will not be professionals in the field of ASD, but they will be trained by the research group on how to access the online tools and how to work whith families. They will contact the participants via phone or video conference on a weekly basis and an in- person visit per month for 3 months. Peer coaches will have a monthly call with participants for an additional nine months.We hope that this study will help the African American and Latino communities receive services sooner than currently reported. We also hope that in the future, parent organizations will use these tools to help families that have recently received an ASD diagnosis will us navigate the complex system of attaining services.
Primary Outcome
This form was created within the research group. It is used monthly after entry to document the services the participants would like to get and the ones they are currently receiving.
Conditions Studied
Interventions
- BEHAVIORAL Access to services via peer coaching
Study Locations (3)
California
- UC Davis - Davis
New York
- University of Rochester - Rochester
Pennsylvania
- UPENN - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
What the finished NCT03711799 record still lists
NCT03711799 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, above the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (16% higher).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Access to services via peer coaching is the first listed.
NCT03711799 reports a single indexed study location in California, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03711799 about?
NCT03711799 is a clinical study titled "Mind the Gap (AIR-B3)". There has been a lack of research on the unique needs of families with autism in the African-American and Latino communities. The process of screening, evaluation and treatment for children with autism can be long and arduous, especially in these communities. This often means that the best intervent...
What is the current status of trial NCT03711799?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2018-04-01. Estimated completion is 2020-08-31.
What conditions does trial NCT03711799 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT03711799?
The interventions under investigation include: Access to services via peer coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03711799?
This trial is sponsored by Health Resources and Services Administration (HRSA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03711799 being conducted?
This trial has 3 study locations across California, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03711799's enrollment target sits among peer trials
156 51st of 224 higher than 174 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI